Endosane Pharmaceuticals
Stefanie Engelhardt has a background in biology and extensive experience in clinical research and project management. Stefanie has held various roles in different companies, focusing on the implementation and monitoring of clinical trials in compliance with guidelines and regulations. Stefanie is currently the Deputy Head of the Research Strategy and Research Funding Unit at Zentralinstitut für Seelische Gesundheit and Head of Quality Assurance at Endosane Pharmaceuticals. In addition to their professional career, Stefanie managed their family during a maternity leave period. Stefanie's expertise also includes mentoring and training junior level employees in the clinical research field.
This person is not in any teams
Endosane Pharmaceuticals
Our Vision is to bring relief to people living with a mental health condition by pioneering a new era in the treatment of neuropsychiatric conditions. In order to fulfil this vision, we are systematically exploring and using the potential of the endocannabinoid system as modulator to restore neurophysiological balance and treat neuropsychiatric and psychiatric conditions.